Thioredoxin induces Tregs to generate an immunotolerant tumor microenvironment in metastatic melanoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thioredoxin induces Tregs to generate an immunotolerant tumor microenvironment in metastatic melanoma
Authors
Keywords
-
Journal
OncoImmunology
Volume 4, Issue 9, Pages e1027471
Publisher
Informa UK Limited
Online
2015-05-28
DOI
10.1080/2162402x.2015.1027471
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antioxidants Accelerate Lung Cancer Progression in Mice
- (2014) V. I. Sayin et al. Science Translational Medicine
- FOXP3 Regulates Sensitivity of Cancer Cells to Irradiation by Transcriptional Repression of BRCA1
- (2013) W. Li et al. CANCER RESEARCH
- IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
- (2013) Geok Choo Sim et al. JOURNAL OF CLINICAL INVESTIGATION
- Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma
- (2013) S. R. Goding et al. JOURNAL OF IMMUNOLOGY
- Regulatory T cells in nonlymphoid tissues
- (2013) Dalia Burzyn et al. NATURE IMMUNOLOGY
- Oxidants, antioxidants and the current incurability of metastatic cancers
- (2013) J. Watson Open Biology
- The Thioredoxin System as a Therapeutic Target in Human Health and Disease
- (2012) Dler Faieeq Darweesh Mahmood et al. ANTIOXIDANTS & REDOX SIGNALING
- Thioredoxin and Thioredoxin Target Proteins: From Molecular Mechanisms to Functional Significance
- (2012) Samuel Lee et al. ANTIOXIDANTS & REDOX SIGNALING
- The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy
- (2012) Lucia Laura Policastro et al. ANTIOXIDANTS & REDOX SIGNALING
- T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
- (2012) A. Facciabene et al. CANCER RESEARCH
- Melanoma: from mutations to medicine
- (2012) H. Tsao et al. GENES & DEVELOPMENT
- Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
- (2012) Joannes FM Jacobs et al. LANCET ONCOLOGY
- Melanoma-induced immunosuppression and its neutralization
- (2012) Viktor Umansky et al. SEMINARS IN CANCER BIOLOGY
- Immunotherapy for Malignant Melanoma Robert
- (2012) Robert Zeiser et al. Current Stem Cell Research & Therapy
- A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens
- (2011) H. Pere et al. BLOOD
- CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
- (2011) E. Righi et al. CANCER RESEARCH
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Regulatory T cells in tumor immunity
- (2010) Hiroyoshi Nishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2
- (2010) J. Bjoern et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Regulatory T-Cell-Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma
- (2009) T. Nicholaou et al. CLINICAL CANCER RESEARCH
- TGF-β and Regulatory T Cell in Immunity and Autoimmunity
- (2008) Yisong Y. Wan et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
- (2008) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started